- Trials with a EudraCT protocol (120)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (16)
120 result(s) found for: Peritoneal dialysis.
Displaying page 1 of 6.
EudraCT Number: 2009-011505-16 | Sponsor Protocol Number: 3.0 | Start Date*: 2010-01-21 | |||||||||||
Sponsor Name:Medizinische Universität Wien,KIM I,Klinische Abteilung für Infektionen u.Tropenmedizin | |||||||||||||
Full Title: Pharmacokinetics of intraperitoneal and intravenous fosfomycin in automated peritoneal dialysis patients without peritonitis | |||||||||||||
Medical condition: A total of 8 patients with renal insufficiency and treatment with automated peritoneal dialysis (APD) will be enrolled into this study evaluating the pharmacokinetics of fosfomycin in this special ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006965-18 | Sponsor Protocol Number: AGO/2006/13 | Start Date*: 2007-02-20 | |||||||||||
Sponsor Name:University Hospital Ghent | |||||||||||||
Full Title: Acute hemodynamische impact van een intraveneuze glucose injectie | |||||||||||||
Medical condition: Peritoneale Dialyse | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003867-76 | Sponsor Protocol Number: RRK4249 | Start Date*: 2013-11-07 | |||||||||||||||||||||||||||||||
Sponsor Name:University Hospitals Birmingham NHS Foundation Trust | |||||||||||||||||||||||||||||||||
Full Title: A prospective, randomised controlled trial to determine the safety and efficacy of steroid impregnated tape compared to standard therapy with silver nitrate in the treatment of over-granulating per... | |||||||||||||||||||||||||||||||||
Medical condition: Over-granulation of peritoneal dialysis exit site in patients with End Stage Renal Failure | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-006928-18 | Sponsor Protocol Number: 06/Q0603/57 | Start Date*: 2007-04-25 | |||||||||||
Sponsor Name:Barts and The London NHS Trust | |||||||||||||
Full Title: Randomised trial of Prontosan wound gel for prevention of exit site infection in peritoneal dialysis patients | |||||||||||||
Medical condition: Peritoneal dialysis patients and their peritoneal dialysis catheter exit site care. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002174-32 | Sponsor Protocol Number: REN00304 | Start Date*: 2005-01-13 | |||||||||||
Sponsor Name:Genzyme Europe BV | |||||||||||||
Full Title: An open label, randomized, parallel design study to investigate the efficacy and safety of sevelamer hydrochloride (Renagel®) compared with calcium acetate in peritoneal dialysis patients (REN00304) | |||||||||||||
Medical condition: Peritoneal dialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) GB (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004360-23 | Sponsor Protocol Number: P-03-235 | Start Date*: 2006-07-03 |
Sponsor Name:Barts and The London NHS Trust | ||
Full Title: Randomised controlled study of “physiological” peritoneal dialysis solutions. | ||
Medical condition: End stage renal failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-005274-30 | Sponsor Protocol Number: UCL_2011_DIDo | Start Date*: 2012-08-27 | |||||||||||
Sponsor Name:Université catholique de Louvain | |||||||||||||
Full Title: Efficacy and safety of a Double Icodextrin Dose in elderly incident CAPD patients on incremental Peritoneal Dialysis therapy: the DIDo study | |||||||||||||
Medical condition: Patients with chronic renal failure who are starting a Continuous Ambulatory Peritoneal Dialysis (CAPD) as first line dialyse. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004004-36 | Sponsor Protocol Number: ZP-PDProtec-102 | Start Date*: 2013-01-14 |
Sponsor Name:Med. Univ. Wien, UK für Kinder und Jugendheilkunde | ||
Full Title: Pilot Study to define the Feasibility of ex-vivo LPS stimulated Cytokine release for Testing Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solutions in Peritoneal Dialysis (PD) | ||
Medical condition: Peritoneal dialysis is a process of removing metabolic waste products and excess water from the patient's body, replacing the function of the diseased kidneys. Currently, despite the clear benef... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016835-36 | Sponsor Protocol Number: PREVIOE-DP | Start Date*: 2011-06-21 | ||||||||||||||||
Sponsor Name:Fundación Investigación Biomédica Hospital Príncipe de Asturias | ||||||||||||||||||
Full Title: ESTUDIO CLÍNICO MULTICÉNTRICO, PROSPECTIVO, ALEATORIZADO, ABIERTO Y CONTROLADO, PARA LA PREVENCIÓN DE LA INFECCIÓN DEL ORIFICIO EXTERNO (IOE) DEL CATÉTER PERITONEAL CON UNA PASTA ANTIBIÓTICA TÓPICA | ||||||||||||||||||
Medical condition: Prevención de la infección del orificio externo (IOE) del catéter peritoneal en pacientes sometidos a diálisis peritoneal por insuficiencia renal crónica. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002984-23 | Sponsor Protocol Number: 33-391ex20/21 | Start Date*: 2021-08-01 |
Sponsor Name:Medical University of Graz | ||
Full Title: Retrospective quantification of anti-SARS-CoV-2 antibody response after mRNA COVID-19 vaccine in patients treated with peritoneal dialysis | ||
Medical condition: Chronic peritoneal dialysis patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005063-28 | Sponsor Protocol Number: Emend2 | Start Date*: 2013-10-02 |
Sponsor Name:University of Gothenburg | ||
Full Title: Release of substance P during peritoneal dialysis: effects of intervention. Controlled cross-over study of the neurokinin-1 receptor antagonist Aprepitant | ||
Medical condition: End stage renal disease under treatment with peritoneal dialysis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005699-33 | Sponsor Protocol Number: 12-179 | Start Date*: 2013-07-22 | |||||||||||
Sponsor Name:CHU Caen | |||||||||||||
Full Title: Etude de la pharmacocinétique de la daptomycine en administration intrapéritonéale chez les patients en dialyse péritonéale présentant une infection péritonéale. | |||||||||||||
Medical condition: renal failure | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000400-42 | Sponsor Protocol Number: ZP-PDProtec-201 | Start Date*: 2014-05-13 |
Sponsor Name:Zytoprotec GmbH | ||
Full Title: Prospective, randomized, multi-center, double-blind, controlled, two-period, two-treatment, crossover, phase II trial to evaluate the safety and efficacy of PD-protec® in peritoneal dialysis in pat... | ||
Medical condition: End Stage Renal Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001520-18 | Sponsor Protocol Number: NL76839.042.21 | Start Date*: 2021-04-09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:RECOVAC consortium | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Long term efficacy and safety of SARS-CoV-2 vaccination in Dutch patients with chronic kidney disease stage G4-G5, on dialysis or after kidney transplantation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: COVID-19 is associated with increased morbidity and mortality in kidney transplant recipients (KTR) and patients with chronic kidneydisease (CKD). Therefore, potential efficacious SARS-CoV-2 vaccin... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-004176-22 | Sponsor Protocol Number: IMPURE-Study | Start Date*: 2017-04-28 |
Sponsor Name:Medizinische Universität Graz | ||
Full Title: IMProving Ultrafiltration and REmoval of uremic toxins by adapted automated peritoneal dialysis in a single center study (IMPURE-Study). | ||
Medical condition: Chronic kidney disease G5D | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-005365-35 | Sponsor Protocol Number: 1449 | Start Date*: 2008-07-20 | |||||||||||
Sponsor Name:Fresenius Medical Care Deutschland GmbH | |||||||||||||
Full Title: Multicentric, parallel, controlled, randomized, single blind clinical evaluation of a new low sodium peritoneal dialysis solution on patients with hypertension treated with continous ambulatory or... | |||||||||||||
Medical condition: Subjects with renal failure treated with peritoneal dialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DE (Completed) FR (Completed) DK (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004053-10 | Sponsor Protocol Number: HN014/HBV-001 | Start Date*: 2006-02-02 |
Sponsor Name:Henogen | ||
Full Title: A phase III, multicentric, multinational, controlled, randomised, open study comparing the immunogenicity, reactogenicity and safety of Henogen’s new adjuvanted hepatitis B vaccine, HB-AS02V, admin... | ||
Medical condition: hepatitis B naïve pre-dialysis, peritoneal dialysis and haemodialysis patients from 15 years of age | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) CZ (Completed) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005434-12 | Sponsor Protocol Number: Nephropaed-PD-01/B | Start Date*: 2008-07-02 | ||||||||||||||||
Sponsor Name:Universitaetsklinikum Erlangen | ||||||||||||||||||
Full Title: Randomized, multicenter cross-over study investigating the effect of bicarbonate-based solutions (Physioneal 35 vs. 40) on protein metabolism in children and adolescents on chronic peritoneal dialysis | ||||||||||||||||||
Medical condition: Pediatric and adolescent patients with end-stage renal failure undergoing chronic peritoneal dialysis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000791-42 | Sponsor Protocol Number: JVM-GLU-12 | Start Date*: 2012-07-26 |
Sponsor Name:FUNDACION INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO LA PRINCESA | ||
Full Title: OPEN, RANDOMIZED AND CONTROLLED STUDY OF SAFETY AND VIABILITY, TO EVALUATE THE NEUROPROTECTIVE EFFECT OF PLASMA GLUTAMATE DIALYSIS IN ACUTE ISCHEMIC STROKE. | ||
Medical condition: BRAIN ISCHEMIC STROKE IN ACUTE PHASE | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-003364-21 | Sponsor Protocol Number: MCI-196-E11 | Start Date*: 2009-06-22 | |||||||||||
Sponsor Name:Mitsubishi Tanabe Pharma Corporation | |||||||||||||
Full Title: A Phase III, Multicentre, Double-blind, Double-Dummy, Randomised, Flexible-dose, Comparative Study of MCI-196 versus Simvastatin for the Treatment of Dyslipidaemia in Subjects with Chronic Kidney D... | |||||||||||||
Medical condition: Dislipidaemia in subjects with Chronic Kidney Disease on Dialysis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) LV (Completed) DK (Completed) IT (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
